Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031

Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031.

Asia Pacific hemodynamic monitoring systems market will grow by 8.0% annually with a total addressable market cap of $4,242.7 million over 2022-2031, driven by the rising prevalence of cardiovascular diseases & diabetes, increasing geriatric population, the introduction of more innovative and non-invasive devices, extensive research and development (R&D) activities, and the increasing healthcare concerns and expenditure amid COVID-19 pandemic.

Highlighted with 28 tables and 41 figures, this 105-page report “Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031 by Component (Catheters, Sensors, Monitoring Devices, Probes, Others), Modality (Invasive, Minimally Invasive, Non-Invasive), Setting (Hospitals, Clinics, Ambulatory Care Units, Homecare, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific hemodynamic monitoring systems market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific hemodynamic monitoring systems market in every aspect of the classification from perspectives of Component, Modality, Setting, and Country.

Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Catheters
• Sensors
• Monitoring Devices
• Probes
• Other Components

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Based on Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Invasive Monitoring
• Minimally Invasive Monitoring
• Non-Invasive Monitoring

By Setting, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Clinics
• Ambulatory Care Units
• Homecare
• Other Settings

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Modality, and Setting over the forecast years are also included.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval


The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Baxter International Inc.
Caretaker, LLC
Cheetah Medical Inc.
CN Systems Medizintechnik GmbH
Deltex Medical Group PLC
Dragerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Flosonics Medical
GE Healthcare
Getinge Group
Heart Kinetics
ICU Medical Inc.
Koninklijke Philips N.V.
Lidco Group PLC
Masimo Corporation
NI Medical Ltd.
Osypka Medical GmbH
Retia Medical
Schwarzer Cardiotek
Sramek BioDynamics Inc.
Uscom Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 13
  • 1.2.6 Market Size/Share Estimation 14
  • 1.2.7 Research Limitations 15
  • 1.3 Executive Summary 16
  • 2 Market Overview and Dynamics 18
  • 2.1 Market Size and Forecast 18
  • 2.1.1 Impact of COVID-19 on World Economy 20
  • 2.1.2 Impact of COVID-19 on the Market 22
  • 2.2 Major Growth Drivers 24
  • 2.3 Market Restraints and Challenges 32
  • 2.4 Emerging Opportunities and Market Trends 35
  • 2.5 Porter’s Fiver Forces Analysis 39
  • 3 Segmentation of Asia Pacific Market by Component 43
  • 3.1 Market Overview by Component 43
  • 3.2 Catheters 45
  • 3.3 Sensors 46
  • 3.4 Monitoring Devices 47
  • 3.5 Probes 48
  • 3.6 Other Components 49
  • 4 Segmentation of Asia Pacific Market by Modality 50
  • 4.1 Market Overview by Modality 50
  • 4.2 Invasive Monitoring 52
  • 4.3 Minimally Invasive Monitoring 53
  • 4.4 Non-Invasive Monitoring 54
  • 5 Segmentation of Asia Pacific Market by Setting 55
  • 5.1 Market Overview by Setting 55
  • 5.2 Hospitals 57
  • 5.3 Clinics 58
  • 5.4 Ambulatory Care Units 59
  • 5.5 Homecare 60
  • 5.6 Other Settings 61
  • 6 Asia-Pacific Market 2021-2031 by Country 62
  • 6.1 Overview of Asia-Pacific Market 62
  • 6.2 Japan 65
  • 6.3 China 68
  • 6.4 Australia 71
  • 6.5 India 73
  • 6.6 South Korea 75
  • 6.7 Rest of APAC Region 77
  • 7 Competitive Landscape 79
  • 7.1 Overview of Key Vendors 79
  • 7.2 New Product Launch, Partnership, Investment, and M&A 82
  • 7.3 Company Profiles 83
  • Baxter International Inc. 83
  • Caretaker, LLC 85
  • Cheetah Medical Inc. 86
  • CN Systems Medizintechnik GmbH 87
  • Deltex Medical Group PLC 88
  • Dragerwerk AG & Co. KGaA 89
  • Edwards Lifesciences Corporation 90
  • Flosonics Medical 91
  • GE Healthcare 92
  • Getinge Group 93
  • Heart Kinetics 94
  • ICU Medical Inc. 95
  • Koninklijke Philips N.V. 96
  • Lidco Group PLC 97
  • Masimo Corporation 98
  • NI Medical Ltd. 99
  • Osypka Medical GmbH 100
  • Retia Medical 101
  • Schwarzer Cardiotek 102
  • Sramek BioDynamics Inc. 103
  • Uscom Ltd. 104
  • RELATED REPORTS 105

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Industry Value Chain Analysis 18
Figure 5. Asia Pacific Hemodynamic Monitoring Systems Market, 2021-2031, $ mn 19
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market 24
Figure 8. Worldwide Prevalence of Cardiovascular Disorders, 1990-2019, million 27
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Hemodynamic Monitoring Systems Market 32
Figure 12. Investment Opportunity Analysis 36
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Hemodynamic Monitoring Systems Market 39
Figure 14. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Component, 2021-2031, % of Revenue 44
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 44
Figure 16. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Catheters, 2021-2031, $ mn 45
Figure 17. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Sensors, 2021-2031, $ mn 46
Figure 18. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Monitoring Devices, 2021-2031, $ mn 47
Figure 19. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Probes, 2021-2031, $ mn 48
Figure 20. Asia Pacific Hemodynamic Monitoring Systems Market by Component: Other Components, 2021-2031, $ mn 49
Figure 21. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Modality, 2021-2031, % of Sales Revenue 51
Figure 22. Asia Pacific Addressable Market Cap in 2022-2031 by Modality, Value ($ mn) and Share (%) 51
Figure 23. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Invasive Monitoring, 2021-2031, $ mn 52
Figure 24. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Minimally Invasive Monitoring, 2021-2031, $ mn 53
Figure 25. Asia Pacific Hemodynamic Monitoring Systems Market by Modality: Non-Invasive Monitoring, 2021-2031, $ mn 54
Figure 26. Breakdown of Asia Pacific Hemodynamic Monitoring Systems Market by Setting, 2021-2031, % of Sales Revenue 56
Figure 27. Asia Pacific Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 56
Figure 28. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Hospitals, 2021-2031, $ mn 57
Figure 29. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Clinics, 2021-2031, $ mn 58
Figure 30. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Ambulatory Care Units, 2021-2031, $ mn 59
Figure 31. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Homecare, 2021-2031, $ mn 60
Figure 32. Asia Pacific Hemodynamic Monitoring Systems Market by Setting: Other Settings, 2021-2031, $ mn 61
Figure 33. Breakdown of APAC Hemodynamic Monitoring Systems Market by Country, 2021 and 2031, % of Revenue 63
Figure 34. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 64
Figure 35. Hemodynamic Monitoring Systems Market in Japan, 2021-2031, $ mn 66
Figure 36. Hemodynamic Monitoring Systems Market in China, 2021-2031, $ mn 69
Figure 37. Hemodynamic Monitoring Systems Market in Australia, 2021-2031, $ mn 71
Figure 38. Hemodynamic Monitoring Systems Market in India, 2021-2031, $ mn 73
Figure 39. Hemodynamic Monitoring Systems Market in South Korea, 2021-2031, $ mn 75
Figure 40. Hemodynamic Monitoring Systems Market in Rest of APAC, 2021-2031, $ mn 77
Figure 41. Growth Stage of Asia Pacific Hemodynamic Monitoring Systems Industry over the Forecast Period 79

List of Tables:

Table 1. Snapshot of Asia Pacific Hemodynamic Monitoring Systems Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. Worldwide Diabetes Prevalence, 2000 — 2045 27
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Hemodynamic Monitoring Systems Market 35
Table 6. Asia Pacific Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 43
Table 7. Asia Pacific Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 50
Table 8. Asia Pacific Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 55
Table 9. APAC Hemodynamic Monitoring Systems Market by Country, 2021-2031, $ mn 63
Table 10. Japan Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 67
Table 11. Japan Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 67
Table 12. Japan Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 67
Table 13. China Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 70
Table 14. China Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 70
Table 15. China Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 70
Table 16. Australia Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 72
Table 17. Australia Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 72
Table 18. Australia Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 72
Table 19. India Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 74
Table 20. India Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 74
Table 21. India Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 74
Table 22. South Korea Hemodynamic Monitoring Systems Market by Component, 2021-2031, $ mn 76
Table 23. South Korea Hemodynamic Monitoring Systems Market by Modality, 2021-2031, $ mn 76
Table 24. South Korea Hemodynamic Monitoring Systems Market by Setting, 2021-2031, $ mn 76
Table 25. Hemodynamic Monitoring Systems Market in Rest of APAC by Country/Region, 2021-2031, $ mn 78
Table 26. Baxter International Inc.: Company Snapshot 83
Table 27. Baxter International Inc.: Business Segmentation 84
Table 28. Baxter International Inc.: Product Portfolio 84
Logo

Asia Pacific Hemodynamic Monitoring Systems Market 2021-2031

Contact usWe are friendly and approachable, give us a call.